Phage diabody repertoires for selection of large numbers of bispecific antibody fragments.
Methods for the generation of large numbers of different bispecific antibodies are presented. Cloning strategies are detailed to create repertoires of bispecific diabody molecules with variability on one or both of the antigen binding sites. This diabody format, when combined with the power of phage display technology, allows the generation and analysis of thousands of different bispecific molecules. Selection for binding presumably also selects for more stable diabodies. Phage diabody libraries enable screening or selection of the best combination bispecific molecule with regards to affinity of binding, epitope recognition and pairing before manufacture of the best candidate.
McGuinness
B T
BT
Cambridge Antibody Technology Ltd., Melbourn, Cambridgeshire, UK.
Walter
G
G
FitzGerald
K
K
Schuler
P
P
Mahoney
W
W
Duncan
A R
AR
Hoogenboom
H R
HR
D000818:Animals; D018033:Antibodies, Bispecific / Q000096:biosynthesis* / Q000235:genetics*; D001435:Bacteriophages / Q000235:genetics; D001483:Base Sequence; D001666:Binding Sites, Antibody / Q000235:genetics; D001709:Biotechnology; D003001:Cloning, Molecular; D004274:DNA, Recombinant / Q000235:genetics; D004076:Digoxigenin / Q000276:immunology; D000939:Epitopes; D006801:Humans; D007128:Immunoglobulin Fragments / Q000096:biosynthesis / Q000235:genetics; D051379:Mice; D010081:Oxazolone / Q000031:analogs & derivatives / Q000276:immunology; D016133:Polymerase Chain Reaction
D018033:Antibodies, Bispecific; D004274:DNA, Recombinant; D000939:Epitopes; D007128:Immunoglobulin Fragments; C018361:2-phenyloxazolone; D010081:Oxazolone; D004076:Digoxigenin